Biological Effects of SARS-CoV Spike Polymorphisms

SARS-CoV 刺突多态性的生物学效应

• 批准号: 6825526
• 负责人: Thomas Miller Gallagher
• 金额: $ 36.01万
• 依托单位: UNIVERSITY OF IOWA
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-07-01 至 2009-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6825526
• 关键词: SARS virus; gene mutation; genetic polymorphism; host organism interaction; immunoprecipitation; nucleic acid sequence; pathologic process; protein structure function; receptor binding; recombinant virus; severe acute respiratory syndrome; tissue /cell culture; virus cytopathogenic effect; virus genetics; virus infection mechanism; virus protein; virus receptors

Severe Acute Respiratory Syndrome (SARS) is a recently recognized epidemic disease characterized by significant morbidity and nearly 10% mortality. The etiologic agent is an enveloped RNA coronavirus. Coronaviruses are prevalent in nature and current findings suggest that the SARS eoronavirus entered the human population from animal reservoirs. Numerous studies have shown that the surface-exposed spike glycoproteins involved in coronavirus binding to host cells are critical factors in epidemiology and pathogenicity. Thus, it is likely that the spike proteins will have a major role in the disease of SARS-CoV infected patients. Therefore, the central objective of this project is to identify and characterize regions of the SARS spike proteins that confer the ability to infect both animals and humans. As part of this objective, we will identify host cell receptors used by SARS-CoV, using soluble spike proteins as detection reagents. As receptors are found, we will proceed by determining whether spike polymorphisms alter affinities for animal or human receptor homologs, as this may explain animal-to-human virus transmissions. We will focus on relevant human airway cells and will identify both cellular and viral determinants of spike-mediated syncytial formation, as syncytia are a recognized hallmark of coronavirus cytopathology. Coronaviruses can accommodate many adaptive mutations in their spike proteins, and we hypothesize that xenotropic and pathogenic SARS-CoVs are distinguished as a subset of these mutant forms. We will advance our understanding of SARS-CoV epidemiology and pathogenesis by identifying these variants and characterizing their receptor binding and syncytium inducing properties.

严重急性呼吸综合征(SARS)是一种新发现的传染病，发病率高，死亡率近10%。病原体是一种包膜的RNA冠状病毒。 冠状病毒在自然界中普遍存在，目前的研究结果表明，SARS冠状病毒是从动物宿主进入人类群体的。大量研究表明，冠状病毒表面暴露的刺突糖蛋白参与冠状病毒与宿主细胞的结合，是流行病学和致病性的关键因素。因此，刺突蛋白很可能在SARS-CoV感染患者的疾病中起主要作用。因此，这个项目的中心目标是识别和表征SARS尖峰蛋白的区域，这些区域赋予了感染动物和人类的能力。作为这一目标的一部分，我们将使用可溶性刺突蛋白作为检测试剂，鉴定SARS-CoV使用的宿主细胞受体。随着受体的发现，我们将继续确定棘突多态是否会改变动物或人类受体同源物的亲和力，因为这可能解释动物到人类的病毒传播。我们将专注于相关的人类呼吸道细胞，并将确定棘波介导的合胞体形成的细胞和病毒决定因素，因为合胞体是冠状病毒细胞病理学的公认标志。冠状病毒可以适应其刺突蛋白中的许多适应性突变，我们假设异嗜性和致病性SARS-CoV是这些突变形式的子集。我们将通过鉴定这些变异体并鉴定它们的受体结合和合胞体诱导特性来促进我们对SARS-CoV流行病学和发病机制的理解。